资讯

Business Insider9 天
BTIG Remains a Buy on Dexcom (DXCM)
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of $107.00. The company’s shares closed last Friday at $66.14.
Business Insider9 天
BTIG Reaffirms Their Buy Rating on Glaukos (GKOS)
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Glaukos (GKOS – Research Report), with a price target of $114.00. The company’s shares closed last Friday at $90.07.